Navigation Links
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Date:5/19/2011

n for the emergence of our PAD program."

"I am pleased to join the Board of Directors of Vermillion," said Bruce Huebner.  "Gail and her management team have made major strides in establishing Vermillion as a leading company in the area of cancer diagnostics.  OVA1 is an innovative product that provides valuable information to the physician for better patient care.  I look forward to helping the management team accelerate the growth of Vermillion."

In addition to serving as a director, Mr. Huebner is expected to lead a special committee of the Board to evaluate the current sales and marketing strategy for OVA1.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health.  Additional information about Vermillion can be found on the Web at www.vermillion.com.

About OVA1®

OVA1® is a qualitative serum test that combines the results of five immunoassays into a single numerical score. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The test utilizes five well-established biomarkers - Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta 2-Microglobulin (Beta 2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) - and a proprietary FDA-cleared software device to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned. Additional information about OVA1® can be found on the Web at www.ova-1.com.

Forward-Looking Statement

Certain
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
2. Vermillion Announces Receipt of NASDAQ Panel Decision
3. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
4. Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code
5. Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
6. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
7. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
8. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
9. Vermillion Announces Issuance of European Patent
10. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
11. Stephens Initiates Coverage on Vermillion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 Green ... million in Series B funding and secured Otter Capital ... investment capital will accelerate commercialization of GGI’s Agriplier™ technology, ... crop types. , “Since our first meeting, we ... to the biological product space,” said Alan Sobba, President ...
(Date:8/27/2014)... Rhythm, a biopharmaceutical company developing peptide therapeutics ... in metabolic disorders, announced today that it has filed ... Securities and Exchange Commission (SEC) relating to the proposed ... The number of shares to be offered and the ... determined. Citigroup and Cowen and Company will ...
(Date:8/27/2014)... 27, 2014 In 2013, ... Lawrence Livermore National Security LLC (LLNS), was ... deliver a state-of-the-art laser system for the European ... under construction in the Czech Republic. , When ... system, called the " High repetition-rate Advanced Petawatt ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... market research report is available in its ... Market 2014-2018 http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... Biodegradable materials are materials that are readily ... packaging differs from conventional non-degradable packaging in ...
Breaking Biology Technology:Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7
... today that Battelle, a science and technology development ... closing its,operations. Financial terms of the acquisition were ... Battelle to transition our assets. In,addition, we will ... our employees," said Leslie Williams, President and CEO,of ...
... BOULDER, Colo., Oct. 29 /PRNewswire/ - N30 Pharma ... and,commercialization of respiratory drugs that target endogenous,s-nitrosothiols, today ... NTMD ) covering the respiratory use of a ... not disclosed. "I am extremely pleased to ...
... 29 Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) announced ... financial results after the Nasdaq market closes on Thursday,November ... be held at 5:00,p.m. Eastern Time (2:00 p.m. Pacific ... by dialing,1-800-894-5910, (US) or 785-424-1052 (International) using the conference,ID: ...
Cached Biology Technology:Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 2
(Date:8/27/2014)... advocates, campaigns against trans-fats have largely succeeded in ... aim at sugar for its potential contributions to ... still wrangling over the best way to assuage ... article in Chemical & Engineering News ... Chemical Society. , In the article, Stephen Ritter, ...
(Date:8/27/2014)... of Adelaide research has shown that piglets can be ... frequency. , The outcome of the study at the ... Reproduction Science , is an important finding for pig ... without loss of production. , "Sows don,t usually start ... heat after their piglets have been weaned," says Ms ...
(Date:8/27/2014)... Gamblers are greedy bird-brains, University of Warwick research finds ... when they make risky decisions, new research has shown. ... University of Warwick,s Department of Psychology, conducted tests that ... more likely to gamble for high-value than low-value rewards. ... argue that the test results show the important role ...
Breaking Biology News(10 mins):Piglet weaning age no bar to litter frequency 2Gamblers are greedy bird-brains, University of Warwick research finds 2
... The American Society for Bone and Mineral Research (ASBMR) ... the world on bone and mineral metabolism, offering an ... new clinical treatments in bone diseases and disorders of ... being held in Baltimore, MD USA, October 4 ...
... immediately in low-resource countries, could have the potential to save ... 2015. Right now the annual global death toll ... Between 2016-2020, these innovations have the potential to save ... The ten, identified by international experts from hundreds of candidates, ...
... dioxide a common ingredient in cosmetics, food products, ... risks associated with the widely used compound. The report ... every year for the global market, appears in the ... Francesco Turci and colleagues explain that titanium dioxide (TiO2) ...
Cached Biology News:American Society for Bone and Mineral Research Annual Meeting Oct. 4-7 2Innovations save lives of mothers and children 2Innovations save lives of mothers and children 3Innovations save lives of mothers and children 4Innovations save lives of mothers and children 5Innovations save lives of mothers and children 6Innovations save lives of mothers and children 7
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... 2 - BSA and Azide free ... applications). Antigen: ... corresponding to C terminal amino acids ... Entrez GeneID: 2064 ...
Anti human PPAR gamma2 mouse monoclonal antibody...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
Biology Products: